188 related articles for article (PubMed ID: 32936304)
21. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
23. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.
Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y
Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024
[TBL] [Abstract][Full Text] [Related]
24. Identification of hub genes and pathways in lung metastatic colorectal cancer.
Dai W; Guo C; Wang Y; Li Y; Xie R; Wu J; Yao B; Xie D; He L; Li Y; Huang H; Wang Y; Liu S
BMC Cancer; 2023 Apr; 23(1):323. PubMed ID: 37024866
[TBL] [Abstract][Full Text] [Related]
25. Identification of hub genes and functional modules in colon adenocarcinoma based on public databases by bioinformatics analysis.
Zhang Z; Luo A; Zeng Z; Zhou Y; Wu W
J Gastrointest Oncol; 2021 Aug; 12(4):1613-1624. PubMed ID: 34532115
[TBL] [Abstract][Full Text] [Related]
26. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract][Full Text] [Related]
27. Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis.
Zhou R; Liu D; Zhu J; Zhang T
Medicine (Baltimore); 2020 Oct; 99(42):e22434. PubMed ID: 33080677
[TBL] [Abstract][Full Text] [Related]
28. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
29. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
30. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
31. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
32. Identification and prognostic analysis of candidate biomarkers for lung metastasis in colorectal cancer.
Liu Y; Liu C; Huang D; Ge C; Chen L; Fu J; Du J
Medicine (Baltimore); 2024 Mar; 103(11):e37484. PubMed ID: 38489730
[TBL] [Abstract][Full Text] [Related]
33. Identification of hub genes correlated with the pathogenesis and prognosis of gastric cancer via bioinformatics methods.
Nie K; Shi L; Wen Y; Pan J; Li P; Zheng Z; Liu F
Minerva Med; 2020 Jun; 111(3):213-225. PubMed ID: 31638362
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
35. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
Sun Q; Liu P; Long B; Zhu Y; Liu T
Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
[TBL] [Abstract][Full Text] [Related]
36. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
37. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.
Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA
BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450
[TBL] [Abstract][Full Text] [Related]
38. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
39. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
[TBL] [Abstract][Full Text] [Related]
40. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.
Dong S; Ding Z; Zhang H; Chen Q
Integr Cancer Ther; 2019; 18():1534735419864434. PubMed ID: 31370719
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]